SEOUL, South Korea — Federal Express Corporation (FedEx) announced a collaboration with the Korea Medical Devices Industry Association (KMDIA) aimed at supporting Korean medical device manufacturers and exporters as they expand into international markets. The initiative focuses on enhancing logistics capabilities, improving export readiness, and providing regulatory guidance to companies within the sector.
KMDIA represents approximately 1,100 member companies, accounting for more than 70% of South Korea’s total medical device exports. Through the collaboration, FedEx plans to provide logistics support and resources designed to strengthen the global competitiveness of Korean medical exporters.
Under the agreement, KMDIA members will receive discounts of up to 60% on FedEx international shipping services, including FedEx International Priority Express, FedEx International Priority, and FedEx International Economy. These services are designed to support time-sensitive shipments and help exporters meet regulatory and delivery requirements across multiple markets.
In addition to shipping discounts, FedEx will offer educational webinars and personalized consultations for KMDIA members. The sessions will cover customs clearance procedures, regulatory compliance considerations, and export best practices. The initiative aims to help manufacturers optimize supply chains and navigate international trade requirements more efficiently.
South Korea’s medical device industry continues to expand, supported by growing global demand for diagnostic reagents, aesthetic laser systems, and rehabilitation equipment. The country’s biohealth sector is projected to grow by 20.8% to reach USD 290 billion in 2026, representing the fastest expansion since 2019. The sector is also expected to reach approximately USD 357 billion by 2029.
To support long-term growth, the South Korean government has announced plans to invest approximately USD 628 million between 2026 and 2032 to accelerate research and development in medical devices. The funding is intended to strengthen innovation and support the sector’s global competitiveness.
FedEx also continues to expand its healthcare logistics capabilities to meet the specialized requirements of life sciences shipments. The company operates six Life Science Centers located in Gimpo, Singapore, Tokyo, Mumbai, Memphis, and Veldhoven, supported by more than 130 cold-chain facilities worldwide. These facilities are designed to support temperature-sensitive and high-value medical shipments.
In addition, FedEx operates 22 facilities under the IATA Center of Excellence for Independent Validators (CEIV) Pharma quality framework, including certified operations at Guangzhou Baiyun International Airport and Kansai International Airport. These certifications are intended to support regulatory compliance and maintain product integrity for international healthcare shipments.
The company also offers monitoring and intervention solutions that use near-real-time sensor data and predictive analytics to track high-value and time-sensitive shipments. These capabilities are designed to improve visibility, support risk management, and enhance supply chain resilience for industries such as healthcare, aerospace, and automotive.
#SupplyChainNews #HealthcareLogistics #GlobalTrade #MedicalDevices #LogisticsNews
